Novel Treatment of Human Melanoma Cells that Express BRAF or NRAS Mutations by Antifungal Agents

被引：0
|
作者：
Koh, David [1 ]
Jira, Lukas [1 ]
McKamey, Shelby [1 ]
机构：
[1] Ohio Northern Univ, Coll Pharm, Ada, OH USA
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.09430
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases
    Zebary, A.
    Jangard, M.
    Omholt, K.
    Ragnarsson-Olding, B.
    Hansson, J.
    BRITISH JOURNAL OF CANCER, 2013, 109 (03) : 559 - 564
  • [42] Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma
    Barel, Fanny
    Guibourg, Briac
    Lambros, Laetitia
    Le Flahec, Glen
    Marcorelles, Pascale
    Uguen, Arnaud
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (01) : 44 - 49
  • [43] Predicting BRAF and NRAS Mutations Using Deep Learning on Histopathology Images of Melanoma
    Kim, Randie
    Nomikou, Sofia
    Dawood, Zarmeena
    Coudray, Nicolas
    Jour, George
    Moran, Una
    Razavian, Narges
    Osman, Iman
    Tsirigos, Aristotelis
    MODERN PATHOLOGY, 2019, 32
  • [44] CpG island hypermethylation profile of human melanoma cell lines in relation to global methylation and mutations in BRAF and NRAS
    Tellez, Carmen S.
    Shen, Lanlan
    Oki, Yasuhiro
    Estecio, Marcos R. H.
    Gershenwald, Jeffrey E.
    Issa, Jean-Pierre J.
    CANCER RESEARCH, 2006, 66 (08)
  • [45] Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors
    Chang, Gregory A.
    Tadepalli, Jyothirmayee S.
    Fleming, Nathaniel H.
    Lui, Kevin
    Shao, Yongzhao
    Darvishian, Farbod
    Pavlick, Anna
    Berman, Russell
    Shapiro, Richard
    Osman, Iman
    Polsky, David
    CANCER RESEARCH, 2015, 75
  • [46] Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma
    Moltara, Maja Ebert
    Novakovic, Srdjan
    Boc, Marko
    Bucic, Marina
    Rebersek, Martina
    Zadnik, Vesna
    Ocvirk, Janja
    RADIOLOGY AND ONCOLOGY, 2018, 52 (03) : 289 - 295
  • [47] Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care
    Heppt, M.
    Siepmann, T.
    Engel, J.
    Schubert-Fritschle, G.
    Eckel, R.
    Mirlach, L.
    Kirchner, T.
    Jung, A.
    Gesierich, A.
    Ruzicka, T.
    Berking, C.
    Flaig, M. J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 3 - 3
  • [48] Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care
    Markus V. Heppt
    Timo Siepmann
    Jutta Engel
    Gabriele Schubert-Fritschle
    Renate Eckel
    Laura Mirlach
    Thomas Kirchner
    Andreas Jung
    Anja Gesierich
    Thomas Ruzicka
    Michael J. Flaig
    Carola Berking
    BMC Cancer, 17
  • [49] Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care
    Heppt, Markus V.
    Siepmann, Timo
    Engel, Jutta
    Schubert-Fritschle, Gabriele
    Eckel, Renate
    Mirlach, Laura
    Kirchner, Thomas
    Jung, Andreas
    Gesierich, Anja
    Ruzicka, Thomas
    Flaig, Michael J.
    Berking, Carola
    BMC CANCER, 2017, 17 : 536
  • [50] BRAF, NRAS, HRAS genes profile in human melanoma cell lines
    Czajkowski, Rafal
    Placek, Waldemar
    Tadrowski, Tadeusz
    Pokrywczynska, Marta
    Zegarska, Barbara
    Drewa, Tomasz
    PRZEGLAD DERMATOLOGICZNY, 2009, 96 (04): : 265 - 270
12345